Jaguar Health Executes 1-for-35 Reverse Split to Meet Nasdaq’s $1.00 Bid Requirement
Jaguar Health completed a 1-for-35 reverse stock split on April 30, 2026, after shareholder approval to satisfy Nasdaq’s requirement for a $1.00 minimum bid price. Its shares, adjusted to a split basis, closed at $7.18 that day, down 8.83%, yielding a market capitalization near $478,500.
1. Reverse Stock Split Implementation
Jaguar Health carried out a 1-for-35 reverse stock split on April 30, 2026, consolidating every 35 existing shares into one to increase its per-share price while maintaining overall shareholder equity.
2. Nasdaq Listing Requirement
The reverse split was designed to comply with Nasdaq’s rule requiring a minimum closing bid price of $1.00 for ten consecutive business days by the May 15, 2026 deadline.
3. Stock Performance and Market Impact
On the effective date, the company’s shares, adjusted for the split, closed at $7.18, reflecting an 8.83% decline and resulting in a market capitalization of approximately $478,500 amid notable 52-week volatility.
4. Shareholder Approval Process
During a special stockholder meeting in April, all five proposals, including the reverse split, were approved, enabling Jaguar Health’s common stock to trade on a split-adjusted basis starting April 30, 2026.